Have a personal or library account? Click to login
Quantitative dosimetric analysis with independent software solutions and comprehensive treatment plan parameter evaluation in skin brachytherapy Cover

Quantitative dosimetric analysis with independent software solutions and comprehensive treatment plan parameter evaluation in skin brachytherapy

Open Access
|Oct 2024

References

  1. Neville JA, Welch E, Leffell DJ. Management of nonmelanoma skin cancer in 2007. Nat Rev Clin Oncol. 2007;4(8):462-469. https://doi.org/10.1038/ncponc0883
  2. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA A Cancer J Clinicians. 2018;68(6):394-424. https://doi.org/10.3322/caac.21492
  3. Madan V, Lear JT, Szeimies RM. Non-melanoma skin cancer. The Lancet. 2010;375(9715):673-685. https://doi.org/10.1016/s0140-6736(09)61196-x
  4. Bath‐Hextall F, Leonardi‐Bee J, Smith C, Meal A, Hubbard R. Trends in incidence of skin basal cell carcinoma. Additional evidence from a UK primary care database study. Intl Journal of Cancer. 2007;121(9):2105-2108. https://doi.org/10.1002/ijc.22952
  5. Gerbaulet A. The GEC ESTRO Handbook of Brachytherapy. ESTRO, Brüssel, 2002
  6. Subashi E, Jacobs C, Hood R, Kirsch DG, Craciunescu O. A design process for a 3D printed patient-specific applicator for HDR brachytherapy of the orbit. 3D Print Med. 2020;6(1). https://doi.org/10.1186/s41205-020-00068-3
  7. Zhao Y, Moran K, Yewondwossen M, et al. Clinical applications of 3-dimensional printing in radiation therapy. Medical Dosimetry. 2017;42(2):150-155. https://doi.org/10.1016/j.meddos.2017.03.001
  8. Park SY, Kang S, Park JM, An HJ, Oh DH, Kim J in. Development and dosimetric assessment of a patient-specific elastic skin applicator for high-dose-rate brachytherapy. Brachytherapy. 2019;18(2):224-232. https://doi.org/10.1016/j.brachy.2018.11.001
  9. Diefenhardt M, Chatzikonstantinou G, Meissner M, et al. HDR brachytherapy with individual epithetic molds for facial skin cancer: techniques and first clinical experience. Int J Dermatology. 2021;60(6):717-723. https://doi.org/10.1111/ijd.15492
  10. Casey S, Bahl G, Awotwi-Pratt JB. High Dose Rate 192-Ir-Brachytherapy for Basal Cell Carcinoma of the Skin using a 3D Printed Surface Mold. Cureus. Published online June 17, 2019. https://doi.org/10.7759/cureus.4913
  11. Arenas M, Sabater S, Sintas A, et al. Individualized 3D scanning and printing for non-melanoma skin cancer brachytherapy: a financial study for its integration into clinical workflow. jcb. 2017;3:270-276. https://doi.org/10.5114/jcb.2017.68134
  12. Bielęda G, Chicheł A, Boehlke M, et al. 3D printing of individual skin brachytherapy applicator: design, manufacturing, and early clinical results. jcb. 2022;14(2):205-214. https://doi.org/10.5114/jcb.2022.114353
  13. Oare C, Wilke C, Ehler E, Mathew D, Sterling D, Ferreira C. Dose calibration of Gafchromic EBT3 film for Ir-192 brachytherapy source using 3D-printed PLA and ABS plastics. 3D Print Med. 2019;5(1). https://doi.org/10.1186/s41205-019-0040-4
  14. Gholami S, Mirzaei HR, et al. A novel phantom design for brachytherapy quality assurance. IJRR. 2016;14(1):67-71. https://doi.org/10.18869/acadpub.ijrr.14.1.67
  15. Hsu SM, Wu CH, Lee JH, et al. A Study on the Dose Distributions in Various Materials from an Ir-192 HDR Brachytherapy Source. Deutsch E, ed. PLoS ONE. 2012;7(9):e44528. https://doi.org/10.1371/journal.pone.0044528
  16. Sinnatamby M, Nagarajan V, Kanipakam RS, Karunanidhi G, Neelakandan V, Kandasamy S. Verification of Radiation Fluence using Stack Film in HDR Brachytherapy with Heterogeneity Algorithm. JCDR. Published online 2018. https://doi.org/10.7860/jcdr/2018/36733.12258
  17. Palmer AL, Bradley D, Nisbet A. Evaluation and implementation of triple‐channel radiochromic film dosimetry in brachytherapy. J Applied Clin Med Phys. 2014;15(4):280-296. https://doi.org/10.1120/jacmp.v15i4.4854
  18. Devic S. Radiochromic film dosimetry: Past, present, and future. Physica Medica. 2011;27(3):122-134. https://doi.org/10.1016/j.ejmp.2010.10.001
  19. Bielęda G, Marach A, Boehlke M, Zwierzchowski G, Malicki J. 3D-printed surface applicators for brachytherapy: a phantom study. jcb. 2021;13(5):549-562. https://doi.org/10.5114/jcb.2021.110304
  20. Wolfsberger LD, Wagar M, Nitsch P, Bhagwat MS, Zygmanski P. Angular dose dependency of MatriXX TM and its calibration. J Applied Clin Med Phys. 2010;11(1):241-251. https://doi.org/10.1120/jacmp.v11i1.3057
  21. Austerlitz C, Campos CAT. A BrachyPhantom for verification of dose calculation of HDR brachytherapy planning system. Medical Physics. 2013;40(11). https://doi.org/10.1118/1.4826170
  22. Yoosuf ABM, Jeevanandam P, Whitten G, Workman G, McGarry CK. Verification of high-dose-rate brachytherapy treatment planning dose distribution using liquid-filled ionization chamber array. JCB. 2018;10(2):142-154. https://doi.org/10.5114/jcb.2018.75599
  23. Poppe B, Stelljes TS, Looe HK, Chofor N, Harder D, Willborn K. Performance parameters of a liquid filled ionization chamber array. Med Phys. 2013;40(8):082106. https://doi.org/10.1118/1.4816298
  24. Sarfehnia A, Kawrakow I, Seuntjens J. Direct measurement of absorbed dose to water in HDR I192r brachytherapy: Water calorimetry, ionization chamber, Gafchromic film, and TG-43. Med Phys. 2010;37(4):1924-1932. https://doi.org/10.1118/1.3352685
  25. Gambarini G, Borroni M, Grisotto S, et al. Solid state TL detectors for in vivo dosimetry in brachytherapy. Applied Radiation and Isotopes. 2012;71:48-51. https://doi.org/10.1016/j.apradiso.2012.06.018
  26. Avilés Lucas P, Lourenço V, Vermesse D, Cutarella D, Aubineau-Lanièce I. Absorbed dose to water distribution measured around an HDR192Ir brachytherapy source by thermoluminescent dosimeters. Metrologia. 2012;49(5):S228-S230. https://doi.org/10.1088/0026-1394/49/5/s228
  27. Bassi S, Berrigan L, Zuchora A, Fahy L, Moore M. End-to-end dosimetric audit: A novel procedure developed for Irish HDR brachytherapy centres. Physica Medica. 2020;80:221-229. https://doi.org/10.1016/j.ejmp.2020.10.005
  28. Lambert J, Nakano T, Law S, Elsey J, McKenzie DR, Suchowerska N. In vivo dosimeters for HDR brachytherapy: A comparison of a diamond detector, MOSFET, TLD, and scintillation detector. Medical Physics. 2007;34(5):1759-1765. https://doi.org/10.1118/1.2727248
  29. Watanabe Y, Maeyama T, Mochizuki A, et al. Verification of dose distribution in high-dose-rate brachytherapy using a nanoclay-based radio-fluorogenic gel dosimeter. Phys Med Biol. 2020;65(17):175008. https://doi.org/10.1088/1361-6560/ab98d2
  30. Venning A, Healy B, Nitschke K, Baldock C. Investigation of the MAGAS normoxic polymer gel dosimeter with Pyrex glass walls for clinical radiotherapy dosimetry. Nuclear Instruments and Methods in Physics Research Section A: Accelerators, Spectrometers, Detectors and Associated Equipment. 2005;555(1-2):396-402. https://doi.org/10.1016/j.nima.2005.09.002
  31. Ibbott GS. Applications of gel dosimetry. J Phys: Conf Ser. 2004;3:58-77. https://doi.org/10.1088/1742-6596/3/1/007
  32. Senkesen O, Tezcanli E, Buyuksarac B, Ozbay I. Comparison of 3D dose distributions for HDR 192Ir brachytherapy sources with normoxic polymer gel dosimetry and treatment planning system. Medical Dosimetry. 2014;39(3):266-271. https://doi.org/10.1016/j.meddos.2014.04.003
  33. Carrara M, Fallai C, Gambarini G, Negri A. Fricke gel-layer dosimetry in high dose-rate brachytherapy. Applied Radiation and Isotopes. 2010;68(4-5):722-725. https://doi.org/10.1016/j.apradiso.2009.09.036
  34. Poder J, Corde S. I‐125 ROPES eye plaque dosimetry: Validation of a commercial 3D ophthalmic brachytherapy treatment planning system and independent dose calculation software with GafChromic® EBT3 films. Medical Physics. 2013;40(12). https://doi.org/10.1118/1.4828786
  35. Pagulayan C, Heng SM, Corde S. Dosimetric validation of the Theragenics AgX-100® I-125 seed for ROPES eye plaque brachytherapy. Australas Phys Eng Sci Med. 2019;42(2):599-609. https://doi.org/10.1007/s13246-019-00761-6
  36. Deufel CL, Furutani KM. Quality assurance for high dose rate brachytherapy treatment planning optimization: using a simple optimization to verify a complex optimization. Phys Med Biol. 2014;59(3):525-540. https://doi.org/10.1088/0031-9155/59/3/525
  37. Dempsey C. Methodology for commissioning a brachytherapy treatment planning system in the era of 3D planning. Australas Phys Eng Sci Med. 2010;33(4):341-349. https://doi.org/10.1007/s13246-010-0036-2
  38. Damato AL, Devlin PM, Bhagwat MS, et al. Independent brachytherapy plan verification software: Improving efficacy and efficiency. Radiotherapy and Oncology. 2014;113(3):420-424. https://doi.org/10.1016/j.radonc.2014.09.015
  39. Shirazi MAM, Faghihi R, Siavashpour Z, Nedaie HA, Mehdizadeh S, Sina S. Independent evaluation of an in‐house brachytherapy treatment planning system using simulation, measurement and calculation methods. J Applied Clin Med Phys. 2012;13(2):103-112. https://doi.org/10.1120/jacmp.v13i2.3687
  40. Ballester F, Puchades V, Lluch JL, et al. Technical note: Monte‐Carlo dosimetry of the HDR 12i and Plus sources. Medical Physics. 2001;28(12):2586-2591. https://doi.org/10.1118/1.1420398
DOI: https://doi.org/10.2478/pjmpe-2024-0020 | Journal eISSN: 1898-0309 | Journal ISSN: 1425-4689
Language: English
Page range: 169 - 176
Submitted on: May 24, 2024
|
Accepted on: Jul 11, 2024
|
Published on: Oct 3, 2024
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2024 Michał Półtorak, Paweł Banatkiewicz, Łukasz Półtorak, Piotr Sobolewski, Damian Zimoń, Maciej Szwast, Irena Walecka, published by Polish Society of Medical Physics
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.